On this page
Susan M. Steele
Insider
First SEC filing: Jan. 6, 2021 · Latest: Jan. 6, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 4, 2021 | HBIO | A | 10,800 | · | · | 49,400 Direct | +27.98% | Acquired | (price as of 2026-10-05) |
| July 1, 2020 | HBIO | A | 1,300 | · | · | 38,600 Direct | +3.49% | Acquired | (price as of 2026-10-05) |
| June 18, 2020 | HBIO | A | 28,100 | · | · | 37,300 Direct | +305.43% | Acquired | (price as of 2026-10-05) |
| May 1, 2020 | HBIO | A | 9,200 | · | · | 9,200 Direct | · | Acquired | (price as of 2026-10-05) |
| April 13, 2020 | HBIO | A | 115,900 | · | · | 115,900 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 13, 2020 | HBIO | Non-Qualified Stock Option (right to buy) | Common Stock, par value $0.01 per share | $2.48 | April 13, 2030 | 115,900 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).